Explore by Category
MCRT Webcast: ASCO/EHA Meeting Review (Part 2)
MC ROUND TABLES - August 04, 2021
Three American-based myeloma specialists discuss the latest trends and studies in part two of the Myeloma Crowd Round Table Webcast on the highlights of the ann... Read More
MCRT Webcast: ASCO/EHA Meeting Review (Part 1)
MC ROUND TABLES - July 23, 2021
The annual American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA) meetings can be considered the “midterms” on t... Read More
MCRT Webcast: Treating Myeloma at the Dana-Farber Cancer Institute
MC ROUND TABLES - July 09, 2021
“It is an honor to come to work every day. We’re inspired every day by our patients and driven to both care effectively for them and advance... Read More
MCRT Webcast: Three Novel Myeloma Therapies (Venetoclax, Melflufen, Ide-cel CAR T)
MC ROUND TABLES - June 30, 2021
Recently three new drug treatments have been added to the treatment arsenal for myeloma, two recently approved by the U.S. Food and Drug Administration (FDA) an... Read More
MCRT Webcast: BCMA and Other Targets
MC ROUND TABLES - May 22, 2021
B-cell maturation agent (BCMA), which is expressed on the surface of virtually all myeloma cells, has been called “the perfect target” by Dr. Nikhil... Read More
MCRT Webcast: What’s Next? Decision-Making for Relapsed/Refractory Myeloma
MC ROUND TABLES - May 18, 2021
“For me, that is the reason why I like taking care of myeloma. You’ve got to be a good listener and you’ve got to be a good historian.... Read More
MCRT Webcast: Fixing Disparities in Myeloma — The Key to Unlock Cures for All?
MC ROUND TABLES - May 09, 2021
People with sub-Saharan African ancestry have more than twice the risk of being diagnosed with myeloma than any other population. According to the most re... Read More
MCRT Webcast: American Society of Hematology Meeting Review (Part 2)
MC ROUND TABLES - March 17, 2021
The American Society of Hematology (ASH) meeting is the most important scientific meeting of the year for the hematology community. The two part Myeloma C... Read More
MCRT Webcast: American Society of Hematology Meeting Review (Part 1)
MC ROUND TABLES - March 07, 2021
The annual American Society of Hematology (ASH) meeting is the most important scientific meeting of the year for the hematology community. It is held annu... Read More
Learning About Myeloma: Myeloma Crowd Round Tables in 2020
MC ROUND TABLES - February 09, 2021
Sometimes we are compelled to learn about things that we never thought would be important in our lives. Ask any myeloma patient or caregiver. That&rsqu... Read More
MCRT Webcast: Side Effects of Myeloma Treatment
MC ROUND TABLES - January 29, 2021
Side effects of various myeloma treatments—chemotherapy, bone-strengthening drugs, monoclonal antibodies, transplant—can be as bad or worse than the... Read More
MCRT Webcast: High-Risk Disease Essentials
MC ROUND TABLES - January 16, 2021
High-risk disease poses the most difficult questions in myeloma treatment. Increasing knowledge about genetics provides information about which targets to... Read More
MCRT Webcast: Why Physicians Are Optimistic About Newly Diagnosed Myeloma
MC ROUND TABLES - January 08, 2021
Fear, uncertainty, and pessimism accompany virtually every cancer diagnosis, especially if most patients, like those with myeloma, have never even heard the wor... Read More
. 
